DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 64 filers reported holding DESIGN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $850,208 | -29.3% | 360,258 | +88.8% | 0.00% | – |
| Q2 2023 | $1,201,839 | +200.2% | 190,768 | +175.0% | 0.00% | – |
| Q1 2023 | $400,305 | -5.8% | 69,377 | +67.5% | 0.00% | – |
| Q4 2022 | $425,010 | -56.9% | 41,424 | -29.7% | 0.00% | – |
| Q3 2022 | $985,000 | +81.1% | 58,935 | +51.8% | 0.00% | – |
| Q2 2022 | $544,000 | +162.8% | 38,832 | +203.0% | 0.00% | – |
| Q1 2022 | $207,000 | -27.4% | 12,816 | -3.7% | 0.00% | – |
| Q4 2021 | $285,000 | +163.9% | 13,304 | +79.7% | 0.00% | – |
| Q3 2021 | $108,000 | +730.8% | 7,404 | +1044.4% | 0.00% | – |
| Q2 2021 | $13,000 | – | 647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |